Pharma & Biotech

Medical technology giant Becton Dickinson enters October with notable momentum, propelled by multiple strategic developments that could signal a potential...

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The biotechnology firm's shares...

Biogen has achieved significant regulatory and clinical milestones for its Alzheimer's treatment Leqembi, positioning the biotechnology firm for potential growth...

The neuroscience sector appears poised for significant transformation, and Axsome Therapeutics is emerging as a potential standout performer. With its...

The healthcare conglomerate Johnson & Johnson is nearing a significant historical achievement. Its stock is closing in on an all-time...

A surge in bullish options trading has drawn significant attention to biotech firm Ocugen, with market participants taking substantial positions...

Investors are celebrating a major turnaround for Valneva as the biopharmaceutical company released compelling long-term results for its Chikungunya vaccine...

Danish pharmaceutical leader Novo Nordisk is confronting significant headwinds as market sentiment shifts dramatically. Morgan Stanley has issued a stark...

The abrupt resignation of Chief Financial Officer Jasper Eenhorst has triggered a sell-off in Redcare Pharmacy shares, creating uncertainty for...

Idorsia Ltd. witnessed an extraordinary trading session yesterday as its stock price skyrocketed without prior indication. The Swiss biotechnology company's...